Anthony is a professor in the Ludwig Institute for Cancer, Melbourne. His research interests are: The molecular mechanisms of signal transduction on the EGF receptor. Within this frame of interest the three dimensional stucture of the EGF receptor ligand TGF has been solved. Clinical trials for the treatment of advanced brain glioma and other tumors with the EGF receptor inhibitor have been developed in Jerusalem.